These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18400455)

  • 41. The endocannabinoid system: from biology to therapy.
    Bifulco M
    Pharmacol Res; 2009 Aug; 60(2):75-6. PubMed ID: 19447179
    [No Abstract]   [Full Text] [Related]  

  • 42. Endocannabinoids as Therapeutic Targets.
    Prospéro-García O; Ruiz Contreras AE; Ortega Gómez A; Herrera-Solís A; Méndez-Díaz M;
    Arch Med Res; 2019 Nov; 50(8):518-526. PubMed ID: 32028095
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endocannabinoids in the regulation of appetite and body weight.
    Kirkham TC
    Behav Pharmacol; 2005 Sep; 16(5-6):297-313. PubMed ID: 16148436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chronic pain in Alzheimer's disease: Endocannabinoid system.
    Blanton H; Reddy PH; Benamar K
    Exp Neurol; 2023 Feb; 360():114287. PubMed ID: 36455638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Endocannabinoid System in the Retina: From Physiology to Practical and Therapeutic Applications.
    Schwitzer T; Schwan R; Angioi-Duprez K; Giersch A; Laprevote V
    Neural Plast; 2016; 2016():2916732. PubMed ID: 26881099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocannabinoid signaling directs periimplantation events.
    Wang H; Xie H; Dey SK
    AAPS J; 2006; 8(2):E425-32. PubMed ID: 16808046
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levels of endocannabinoids and palmitoylethanolamide and their pharmacological manipulation in chronic granulomatous inflammation in rats.
    ; De Filippis D; D'Amico A; Cipriano M; Petrosino S; Orlando P; Di Marzo V; Iuvone T
    Pharmacol Res; 2010 Apr; 61(4):321-8. PubMed ID: 19931394
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Therapeutic potential of the endocannabinoid system in the brain.
    Ramos JA; González S; Sagredo O; Gómez-Ruiz M; Fernández-Ruiz J
    Mini Rev Med Chem; 2005 Jul; 5(7):609-17. PubMed ID: 16026307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endocannabinoids and food intake: newborn suckling and appetite regulation in adulthood.
    Fride E; Bregman T; Kirkham TC
    Exp Biol Med (Maywood); 2005 Apr; 230(4):225-34. PubMed ID: 15792943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Retrograde signalling by endocannabinoids.
    Vaughan CW; Christie MJ
    Handb Exp Pharmacol; 2005; (168):367-83. PubMed ID: 16596781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The evolving role of the endocannabinoid system in gynaecological cancer.
    Ayakannu T; Taylor AH; Willets JM; Konje JC
    Hum Reprod Update; 2015; 21(4):517-35. PubMed ID: 25958409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting the endocannabinoid system in treating brain disorders.
    Bahr BA; Karanian DA; Makanji SS; Makriyannis A
    Expert Opin Investig Drugs; 2006 Apr; 15(4):351-65. PubMed ID: 16548785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Short- and long-term plasticity of the endocannabinoid system in neuropsychiatric and neurological disorders.
    Bisogno T; Di Marzo V
    Pharmacol Res; 2007 Nov; 56(5):428-42. PubMed ID: 17933549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anandamide receptor signal transduction.
    Goodfellow CE; Glass M
    Vitam Horm; 2009; 81():79-110. PubMed ID: 19647109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocannabinoids and their involvement in the neurovascular system.
    Battista N; Fezza F; Maccarrone M
    Curr Neurovasc Res; 2004 Apr; 1(2):129-40. PubMed ID: 16185189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Reductions in endocannabinoid levels and enhanced coupling of cannabinoid receptors in the striatum are accompanied by cognitive impairments in the AβPPswe/PS1ΔE9 mouse model of Alzheimer's disease.
    Maroof N; Ravipati S; Pardon MC; Barrett DA; Kendall DA
    J Alzheimers Dis; 2014; 42(1):227-45. PubMed ID: 24844690
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Endocannabinoids and liver disease--review.
    Gabbay E; Avraham Y; Ilan Y; Israeli E; Berry EM
    Liver Int; 2005 Oct; 25(5):921-6. PubMed ID: 16162147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The endogenous cannabinoid system and its role in nociceptive behavior.
    Cravatt BF; Lichtman AH
    J Neurobiol; 2004 Oct; 61(1):149-60. PubMed ID: 15362158
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Review article: the endocannabinoid system in liver disease, a potential therapeutic target.
    Basu PP; Aloysius MM; Shah NJ; Brown RS
    Aliment Pharmacol Ther; 2014 Apr; 39(8):790-801. PubMed ID: 24612021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The endocannabinoid system and Huntington's disease.
    Lastres-Becker I; De Miguel R; Fernández-Ruiz JJ
    Curr Drug Targets CNS Neurol Disord; 2003 Oct; 2(5):335-47. PubMed ID: 14529364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.